Determination of Oxidation Phenotype by Measurement of Propafenone Urinary Metabolic Ratios

Abstract

Get full access to this article

View all access options for this article.

References

Brøsen K. Recent developments in hepatic drug oxidation: Implications for clinical pharmacokinetics . Clinical Pharmacokinetics 1990; 18: 220-39.

Sjöqvist F. Slow drug hydroxylation: Implications for patient management and drug utilization . In: Xenobiotic Metabolism and Disposition, Proceedings of the 2nd International ISSX Meeting, Kobe, Japan, May 16-20, R. Kato, R.W. Estabrook and M.N. Cayen (eds), London, Taylor & Francis, 1989, pp. 475-82.

Dahl-Puustinen ML , Lidén A. , Alm C. , Nordin C. & Bertilsson L. Disposition of perphenazine is related to the polymorphic debrisoquine hydroxylation in human beings. Clinical Pharmacology and Therapeutics 1989; 46: 78-81.

Siddoway LA , Thompson KA , McAllister CB et al. Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences. Circulation 1987; 75: 785-91.

Beckmann J. , Hertrampf R. , Gundert-Remy U. , Mikus G. , Gross AS & Eichelbaum M.

Is there a genetic factor in flecainide toxicity?

British Medical Journal 1988; 297: 1396.

Lledó P. , Abrams Sml , Johnston A. & Pearson RM

Mexiletine pharmacokinetics and debrisoquine hydroxylator status. European

Journal of Pharmacology 1990; 183: 2387.

Funck-Brentano C. , Kroemer HK , Pavlou H. , Woosley, RL & Roden DM Genetically determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effect. British Journal of Clinical Pharmacology 1989; 27: 435-444.

Lledó-Polo MP , PhD Thesis, University of London, 1991.

Lennard MS , Silas JH , Smith AJ & Tucker GT Determination of debrisoquine and its 4-hydroxymetabolite in biological fluids by gas chromatography with flame ionization and nitrogen-selective detection . Journal of Chromatography 1977; 177: 161-166.

10.

Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. New England Journal of Medicine 1989; 321: 406-12.